BioSpace News Archive

Fiscal Year 2020 Adjusted Total Revenue - $71.0 million - - Fiscal Year 2020 Adjusted EBITDA - $28.4 million - - Blexten Canadian Prescriptions Increased 35% Year-Over-Year - - Cambia Canadian Prescriptions Increased 17% Year-Over-Year - Miravo to Host Conference Call/Audio Webcast March 8th at 11:00 a.m. ET

LabVantage Solutions, Inc., the leading provider of laboratory informatics solutions and services including purpose-built LIMS solutions that allow labs to go live faster and at a lower total cost, announced it has added validation to a number of its subscription-based LIMS.

Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced that Sabrina Martucci Johnson, its President and Chief Executive Officer, will participate in a panel discussion titled “Women’s Health Companies Blazing the Trail” at the 33 rd Annual Roth Conference that will take place virtually March 15 – 17, 2021.

The demand within the global pharmaceutical grade lactose market has been rising on account of advancements in the pharmaceutical industry.

Rapidly growing popularity of minimally invasive surgical options such as LASIK will accelerate demand for ophthalmic surgical systems in future years.

The rising cases of acute and chronic diseases and the increasing number of therapeutic surgeries are likely to emerge as the key factors driving the global medical tapes and bandages market during the forecast period, 2020 to 2030.

Genentech, a member of the Roche Group, announced that the company is voluntarily withdrawing the U.S. indication for Tecentriq® in prior-platinum treated metastatic urothelial carcinoma.

Oncopeptides AB, a global biotech company focused on the development of therapies for difficult-to-treat hematological diseases, announced that it strengthens the leadership of the European operations by appointing Andrea Passalacqua as General Manager in Europe, and Pamela Bacon as Head of Medical Affairs Europe.

Calliditas Therapeutics AB announced the appointment of three industry veterans: Warren Brooks, PhD, as Vice President of US Medical Affairs, Teona Johnson as Head of US Marketing and David Ferraro as Head of US Sales.

Medivir AB announces that the company will present at the virtual meeting H.C. Wainwright Global Life Sciences Conference, March 9-10.